X4 Pharmaceuticals, Inc. Common Stock
€3.465
EUR
Last updated on --.
24h volume213.39K
24h highest3.5795 EUR
24h lowest3.4228 EUR
24h Price movement+0.75%
XFOR recent prices
24 Hours
+0.75%+€0.0258
30 days
-2.06%-€0.0731
60 days
+1.13%+€0.0387
90 days
+17.30%+€0.5117
Key data
Previous close3.4400 EUR
Market cap305.80M EUR
Volume213.39K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.91160 EUR
Net income (FY)-85.76M EUR
Revenue (FY)7.75M EUR
Last report dateMay 6, 2026
About X4 Pharmaceuticals, Inc. Common Stock
HeadquartersBOSTON
Employees (FY)45.00
Revenue per employee (FY)172.27K EUR
Net income per employee (FY)-1.91M EUR
Listed onNasdaq
XFOR conversion tables
 |  |
|---|---|
| 0.5 XFOR | 1.732 EUR |
| 1 XFOR | 3.465 EUR |
| 5 XFOR | 17.32 EUR |
| 10 XFOR | 34.65 EUR |
| |
|---|---|
| 0.5 EUR | 0.14427 XFOR |
| 1 EUR | 0.28853 XFOR |
| 5 EUR | 1.442 XFOR |
| 10 EUR | 2.885 XFOR |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
XFOR is trading at €3.465, +0.75% over the last 24 hours. Track live moves on the price chart at the top of this page.
The XFOR stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. XFOR is currently trading at €3.465, +0.75% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on XFOR price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. XFOR's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from XFOR; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against XFOR's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
X4 Pharmaceuticals, Inc. Common Stock's market cap is currently 305.80M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume213.39K
24h highest3.5795 EUR
24h lowest3.4228 EUR
24h Price movement+0.75%
Start trade with XFOR Perpetual
Sign up to trade